Colombini A, Guillermet E, Dicko HM, Mai LT, Hane F, Jaillard P, Gessner BD. Optimal approaches for the use of DTP-HepB-Hib vaccine in a compact prefilled auto disable (cPAD) syringe in resource-poor settings. Poster presen- tation. 16th International Congress on Infectious Diseases, ...
Hib3从74%降至72%; IPV1从83%降至80%; Pol3从83%降至81%; RCV从69%降至66%。 2023年,全球IPV1覆盖率恢复至2019年水平(83%)。尽管2020年疫苗引入中断,但在2019-2023年间引入了18种疫苗,包括HepB-BD(9个国家)和轮状病毒疫苗(17个国家)。2019-2023年间,IPV2在58个使用口服脊灰疫苗的国家引入;到...
The decision to introduce a new vaccine and/or change the format of presentation generally may be influenced by (1) vaccine price, due to the lower price per dose of the MDV compared with the SDV or cPAD such as Uniject™, (2) cold chain requirements, with the MDV occupying less spac...
ScienceDirect® is a registered trademark of Elsevier B.V. Cookies are used by this site. To decline or learn more, visit our Cookies page Switch to Mobile Site Recommended articles No articles found. Citing articles (0) This article has not been cited. Related book content No ...
Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: evidence from a comparative time-motion study in India. Vaccine 2009;27:655-9.Wiedenmayer K, Weiss S, Chattopadhyay C, et al. Simplify- ing paediatric immunization with a fully liquid dTPHepB-Hib ...
Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: evidence from a comparative time-motion study in India. Vaccine 2009;27:655-9.Wiedenmayer K, Weiss S, Chattopadhyay C, et al. Simplify- ing paediatric immunization with a fully liquid dTPHepB-Hib ...